Axel Regeniter

3.2k total citations · 1 hit paper
41 papers, 1.5k citations indexed

About

Axel Regeniter is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Axel Regeniter has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 8 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Axel Regeniter's work include Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (5 papers). Axel Regeniter is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (5 papers). Axel Regeniter collaborates with scholars based in Switzerland, Germany and United Kingdom. Axel Regeniter's co-authors include Jens Kühle, Raija L.P. Lindberg, Matthias Mehling, Ludwig Kappos, David Leppert, Axel Petzold, Andreas U. Monsch, W Siede, Ahuva Nissim and Gavin Giovannoni and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Chemistry.

In The Last Decade

Axel Regeniter

40 papers receiving 1.5k citations

Hit Papers

Increased Neurofilament L... 2013 2026 2017 2021 2013 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Axel Regeniter 614 377 347 272 193 41 1.5k
Michael Pike 616 1.0× 459 1.2× 220 0.6× 152 0.6× 126 0.7× 61 1.9k
Åsa Sandelius 440 0.7× 334 0.9× 178 0.5× 223 0.8× 163 0.8× 18 1.1k
Franz Blaes 928 1.5× 202 0.5× 199 0.6× 524 1.9× 160 0.8× 76 1.9k
Ahmed Abdelhak 670 1.1× 388 1.0× 497 1.4× 206 0.8× 65 0.3× 34 1.7k
André Huss 702 1.1× 596 1.6× 467 1.3× 463 1.7× 97 0.5× 39 1.9k
Tatsuo Kohriyama 988 1.6× 592 1.6× 222 0.6× 179 0.7× 148 0.8× 104 2.2k
K Tashiro 740 1.2× 705 1.9× 480 1.4× 132 0.5× 113 0.6× 143 2.4k
Roumen Balabanov 803 1.3× 634 1.7× 608 1.8× 134 0.5× 98 0.5× 46 2.6k
Hannu Tuominen 194 0.3× 411 1.1× 370 1.1× 229 0.8× 80 0.4× 72 1.7k
Mastura Monif 537 0.9× 419 1.1× 195 0.6× 122 0.4× 49 0.3× 90 1.8k

Countries citing papers authored by Axel Regeniter

Since Specialization
Citations

This map shows the geographic impact of Axel Regeniter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Regeniter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Regeniter more than expected).

Fields of papers citing papers by Axel Regeniter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Regeniter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Regeniter. The network helps show where Axel Regeniter may publish in the future.

Co-authorship network of co-authors of Axel Regeniter

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Regeniter. A scholar is included among the top collaborators of Axel Regeniter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Regeniter. Axel Regeniter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ziegler, Mario, et al.. (2023). Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis. Frontiers in Immunology. 14. 1237149–1237149. 5 indexed citations
3.
Regeniter, Axel, et al.. (2021). Accuracy of urine flow cytometry and urine test strip in predicting relevant bacteriuria in different patient populations. BMC Infectious Diseases. 21(1). 209–209. 5 indexed citations
4.
Bastard, Jean‐Philippe, Soraya Fellahi, Axel Regeniter, et al.. (2019). Aside from acute renal failure cases, are urinary markers of glomerular and tubular function useful in clinical practice?. Clinical Biochemistry. 65. 1–6. 5 indexed citations
5.
Regeniter, Axel & W Siede. (2017). Peaks and tails: Evaluation of irregularities in capillary serum protein electrophoresis. Clinical Biochemistry. 51. 48–55. 30 indexed citations
6.
Prabakaran, Thaneas, Henrik Birn, Bo Martin Bibby, et al.. (2013). Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease. Nephrology Dialysis Transplantation. 29(3). 619–625. 25 indexed citations
7.
Norgren, Niklas, Ruth Dobson, Joanne Topping, et al.. (2013). Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases. PLoS ONE. 8(9). e75091–e75091. 366 indexed citations breakdown →
8.
Regeniter, Axel, Jens Kühle, Thomas Baumann, et al.. (2012). Biomarkers of dementia: Comparison of electrochemiluminescence results and reference ranges with conventional ELISA. Methods. 56(4). 494–499. 10 indexed citations
9.
Baumann, Thomas, Marc Sollberger, Jens Kühle, et al.. (2010). CSF-Tau and CSF-Aβ<sub>1–42</sub> in Posterior Cortical Atrophy. Dementia and Geriatric Cognitive Disorders. 29(6). 530–533. 29 indexed citations
10.
Kühle, Jens, Axel Regeniter, David Leppert, et al.. (2010). A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. Journal of Neuroimmunology. 220(1-2). 114–119. 69 indexed citations
11.
Kohler, Maxie, Stefan Franz, Axel Regeniter, et al.. (2009). Comparison of the urinary protein patterns of athletes by 2D‐gel electrophoresis and mass spectrometry—a pilot study. Drug Testing and Analysis. 1(8). 382–386. 17 indexed citations
12.
Regeniter, Axel, et al.. (2009). Evaluation of proteinuria and GFR to diagnose and classify kidney disease: Systematic review and proof of concept. European Journal of Internal Medicine. 20(6). 556–561. 15 indexed citations
13.
Kühle, Jens, Raija L.P. Lindberg, Axel Regeniter, et al.. (2009). Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European Journal of Neurology. 16(6). 771–774. 147 indexed citations
14.
Regeniter, Axel, Jens Kühle, Matthias Mehling, et al.. (2009). A modern approach to CSF analysis: Pathophysiology, clinical application, proof of concept and laboratory reporting. Clinical Neurology and Neurosurgery. 111(4). 313–318. 40 indexed citations
15.
Siede, W, et al.. (2008). Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins. Clinical Chemistry and Laboratory Medicine (CCLM). 46(10). 1468–9. 2 indexed citations
16.
Mehling, Matthias, Jens Kühle, & Axel Regeniter. (2008). 10 Most Commonly Asked Questions About Cerebrospinal Fluid Characteristics in Demyelinating Disorders of the Central Nervous System. The Neurologist. 14(1). 60–65. 6 indexed citations
17.
Kühle, Jens, Raija L.P. Lindberg, Axel Regeniter, et al.. (2007). Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. Journal of Neurology. 254(2). 160–168. 38 indexed citations
18.
Regeniter, Axel, et al.. (2000). Interpreting complex urinary patterns with mdi lablink: a statistical evaluation. Clinica Chimica Acta. 297(1-2). 261–273. 22 indexed citations
19.
Regeniter, Axel, W Siede, & U Seiffert. (1996). Computer assisted interpretation of laboratory test data with ‘MDI-LabLink’. Clinica Chimica Acta. 248(1). 107–118. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026